Outcome Prediction at Patient Level Derived from Pre-Treatment 18F-FDG PET Due to Machine Learning in Metastatic Melanoma Treated with Anti-PD1 Treatment

(1) Background: As outcome of patients with metastatic melanoma treated with anti-PD1 immunotherapy can vary in success, predictors are needed. We aimed to predict at the patients’ levels, overall survival (OS) and progression-free survival (PFS) after one year of immunotherapy, based on their pre-t...

Description complète

Détails bibliographiques

Auteurs principaux:	Anthime Flaus, Vincent Habouzit, Nicolas de Leiris, Jean-Philippe Vuillez, Marie-Thérèse Leccia, Mathilde Simonson, Jean-Luc Perrot, Florent Cachin, Nathalie Prevot
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2022-02-01
Collection:	Diagnostics
Sujets:	18F-FDG PET radiomics machine-learning immunotherapy melanoma prediction
Accès en ligne:	https://www.mdpi.com/2075-4418/12/2/388
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!